[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Veradermics Incorporated (MANE)

Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,294,983
  • Shares Outstanding, K 41,780
  • Annual Sales, $ 0 K
  • Annual Income, $ -70,000 K
  • EBIT $ -88 M
  • EBITDA $ -88 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.26

Options Overview Details

View History
  • Implied Volatility 97.57% (-8.88%)
  • Historical Volatility 53.26%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 111.66% on 07/17/26
  • IV Low 97.57% on 08/27/26
  • Expected Move (DTE 22) 18.21 (17.77%)
  • Put/Call Vol Ratio 1.04
  • Today's Volume 49
  • Volume Avg (30-Day) 72
  • Put/Call OI Ratio 2.95
  • Today's Open Interest 466
  • Open Int (30-Day) 1,006
  • Expected Range 84.26 to 120.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.59
  • Number of Estimates 1
  • High Estimate $-0.59
  • Low Estimate $-0.59
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.77 +9.42%
on 08/03/26
117.40 -12.60%
on 08/19/26
-8.82 (-7.92%)
since 07/27/26
3-Month
86.83 +18.16%
on 06/18/26
131.24 -21.82%
on 07/01/26
+2.47 (+2.47%)
since 05/27/26

Most Recent Stories

More News
Veradermics: Q2 Earnings Snapshot

Veradermics: Q2 Earnings Snapshot

MANE : 102.08 (-0.70%)
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

Positive topline results from open-label Phase 2 Study ‘207’ evaluating VDPHL01 in female pattern hair loss demonstrated rapid onset and consistent hair growth Completion...

MANE : 102.08 (-0.70%)
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced the presentation...

MANE : 102.08 (-0.70%)
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout

VDPHL01, a novel orally-administered extended-release minoxidil formulation, achieved fast onset of hair growth with the majority of study participants reporting improvement in hair coverage as early as...

MANE : 102.08 (-0.70%)
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss

Conference call will take place on Wednesday, July 15, 2026 at 8:00 am ET

MANE : 102.08 (-0.70%)
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

SEATTLE and VANCOUVER, British Columbia, June 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (“Achieve” or the “Company”) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company...

MANE : 102.08 (-0.70%)
TARS : 71.79 (+1.61%)
ACHV : 8.34 (+0.85%)
Veradermics to Present at Upcoming June Investor Conferences

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 102.08 (-0.70%)
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 102.08 (-0.70%)
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium

Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that...

MANE : 102.08 (-0.70%)
Veradermics: Q1 Earnings Snapshot

Veradermics: Q1 Earnings Snapshot

MANE : 102.08 (-0.70%)

Business Summary

Veradermics Incorporated is a late clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment in prevalent aesthetic and dermatological conditions. Veradermics Incorporated is based in NEW HAVEN, Conn.

See More

Key Turning Points

3rd Resistance Point 108.25
2nd Resistance Point 106.56
1st Resistance Point 104.68
Last Price 102.08
1st Support Level 101.11
2nd Support Level 99.42
3rd Support Level 97.54

See More

52-Week High 131.24
Last Price 102.08
Fibonacci 61.8% 93.33
Fibonacci 50% 81.62
Fibonacci 38.2% 69.91
52-Week Low 32.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.